Significance of the vascular renin-angiotensin pathway.
D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000502:physiology*; D000818:Animals; D001808:Blood Vessels / Q000187:drug effects / Q000502:physiology*; D002216:Captopril / Q000494:pharmacology / Q000627:therapeutic use; D004656:Enalapril / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology*; D006978:Hypertension, Renovascular / Q000503:physiopathology; D011943:Receptors, Adrenergic, beta / Q000187:drug effects / Q000502:physiology; D012083:Renin / Q000502:physiology*; D012084:Renin-Angiotensin System / Q000187:drug effects; D014655:Vascular Resistance; D000092502:Renin Inhibitors
D000804:Angiotensin II; D002216:Captopril; D004656:Enalapril; D011943:Receptors, Adrenergic, beta; D012083:Renin; D000092502:Renin Inhibitors